CONTRAVISORY INVESTMENT MANAGEMENT, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
CONTRAVISORY INVESTMENT MANAGEMENT, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$292,479
+6.4%
3,265
+1.1%
0.08%
+13.7%
Q2 2023$274,832
+2.9%
3,2280.0%0.07%
-2.7%
Q1 2023$267,117
+4092.7%
3,228
+3885.2%
0.08%
+3650.0%
Q4 2022$6,371
+6.2%
810.0%0.00%0.0%
Q3 2022$6,000
+20.0%
810.0%0.00%0.0%
Q2 2022$5,000
-97.2%
81
-98.5%
0.00%
-95.2%
Q3 2015$178,000
-21.6%
5,5000.0%0.04%
-14.3%
Q2 2015$227,000
-8.1%
5,5000.0%0.05%
-2.0%
Q1 2015$247,0005,5000.05%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders